English

NOVEN PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2009-08-06

64 filing records in this dataset, filed from 1995-05-12 to 2009-08-06. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

26.8 million USD

2009-06-30 · USD

Exact inputs and evidence

Revenue: 26771000 USD Source

Operating margin

-10.2%

2009-06-30 · %

Exact inputs and evidence

Operating Income: -2731000 USD Source
Revenue: 26771000 USD Source

Cash and cash equivalents: 69.8 million USD 2009-06-30 Source
Exact value

69773000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

117 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Revenue: 25705000 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 108175000 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 71790000 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 27640000 USD · 2009-01-01 – 2009-03-31 Source
Revenue: 26771000 USD · 2009-04-01 – 2009-06-30 Source

Net income

26.1 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Net income: 5204000 USD · 2008-07-01 – 2008-09-30 Source
Net income: 21412000 USD · 2008-01-01 – 2008-12-31 Source
Net income: 12306000 USD · 2008-01-01 – 2008-09-30 Source
Net income: 4497000 USD · 2009-01-01 – 2009-03-31 Source
Net income: 7271000 USD · 2009-04-01 – 2009-06-30 Source

Operating cash flow

19.6 million USD

2008-01-01 – 2008-12-31

Exact inputs and evidence

Operating cash flow: -4076000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -9913000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -4076000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: 21318000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -9913000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: 19597000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: 21318000 USD · 2008-01-01 – 2008-09-30 Source

Capital expenditure

4.8 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Capital expenditure: 2997000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 1205000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 3820000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 2997000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 798000 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 2185000 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 798000 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-08-06.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2008-12-31
Operating income: 4 of 11 periods available· newest 2008-12-31
Net income: 4 of 11 periods available· newest 2008-12-31
Operating cash flow: 4 of 11 periods available· newest 2008-12-31
Capital expenditure: 4 of 11 periods available· newest 2008-12-31
Total assets: 4 of 11 periods available· newest 2008-12-31
Total liabilities: 3 of 11 periods available· newest 2008-12-31
Current assets: 4 of 11 periods available· newest 2008-12-31
Current liabilities: 4 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+30.1%

Prior period

USD 83.16 million

2007-01-01 – 2007-12-31
Current period

USD 108.18 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

108175000 − 83161000 = 25014000 USD

83161000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
108175000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NOVEN PHARMACEUTICALS INC · 2008-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Year-over-year change in Revenue: 25014000 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 108175000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#18726 Input fundies:Revenue: 83161000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#18726
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 66.79 million

Prior period

−USD 45.38 million

2007-01-01 – 2007-12-31
Current period

USD 21.41 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

21412000 − -45376000 = 66788000 USD

-45376000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
21412000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NOVEN PHARMACEUTICALS INC · 2008-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Year-over-year change in Net income: 66788000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 21412000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20442 Input fundies:NetIncome: -45376000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20442
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-64%

Prior period

USD 54.37 million

2007-01-01 – 2007-12-31
Current period

USD 19.6 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

19597000 − 54369000 = -34772000 USD

54369000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
19597000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NOVEN PHARMACEUTICALS INC · 2008-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Year-over-year change in Operating cash flow: -34772000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 19597000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20891 Input fundies:OperatingCashFlow: 54369000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20891
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+38.8%

Prior period

USD 2.75 million

2007-01-01 – 2007-12-31
Current period

USD 3.82 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

3820000 − 2753000 = 1067000 USD

2753000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
3820000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NOVEN PHARMACEUTICALS INC · 2008-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Year-over-year change in Capital expenditure: 1067000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3820000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20933 Input fundies:CapitalExpenditure: 2753000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20933
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 108.18 million 100% of revenue
Operating costs Derived USD 122.48 million 113% of revenue
Operating income −USD 14.31 million −13% of revenue
Tax, interest and other Derived −USD 35.72 million −33% of revenue
Net income USD 21.41 million 20% of revenue

Cash

Operating cash flow USD 19.6 million 18% of revenue
Capital expenditure USD 3.82 million 3.5% of revenue
Free cash flow Derived USD 15.78 million 15% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Operating loss: operating costs were 122% of revenue.
2006 Operating loss: operating costs were 115% of revenue.
2007 Operating loss: operating costs were 234% of revenue.
2008 Operating loss: operating costs were 113% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2005-01-01 – 2005-12-31	52532000	64177000 Derived	-11645000	-21617000 Derived	9972000	-9784000 Derived	Source 2005-01-01 – 2005-12-31: 52532000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -11645000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 9972000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 3885000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 13669000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	60689000	69663000 Derived	-8974000	-24962000 Derived	15988000	53766000 Derived	Source 2006-01-01 – 2006-12-31: 60689000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -8974000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 15988000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 60027000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 6261000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	83161000	194716000 Derived	-111555000	-66179000 Derived	-45376000	51616000 Derived	Source 2007-01-01 – 2007-12-31: 83161000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -111555000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -45376000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 54369000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 2753000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	108175000	122483000 Derived	-14308000	-35720000 Derived	21412000	15777000 Derived	Source 2008-01-01 – 2008-12-31: 108175000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -14308000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 21412000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 19597000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 3820000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 108.2M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Revenue	52532000	Revenue: 52532000 Open source
20062006-12-31	Revenue	60689000	Revenue: 60689000 Open source
20072007-12-31	Revenue	83161000	Revenue: 83161000 Open source
20082008-12-31	Revenue	108175000	Revenue: 108175000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

30.1% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 52532000 Open source
20062006-12-31	Year over year	15.5%	Revenue: 60689000 Open source Revenue: 52532000 Open source
20072007-12-31	Year over year	37%	Revenue: 83161000 Open source Revenue: 60689000 Open source
20082008-12-31	Year over year	30.1%	Revenue: 108175000 Open source Revenue: 83161000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -13.2% 2008

Net margin 19.8% 2008

Free cash flow margin 14.6% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Operating margin	-22.2%	Operating Income: -11645000 Open source Revenue: 52532000 Open source
20062006-12-31	Operating margin	-14.8%	Operating Income: -8974000 Open source Revenue: 60689000 Open source
20072007-12-31	Operating margin	-134.1%	Operating Income: -111555000 Open source Revenue: 83161000 Open source
20082008-12-31	Operating margin	-13.2%	Operating Income: -14308000 Open source Revenue: 108175000 Open source
20052005-12-31	Net margin	19%	Net Income: 9972000 Open source Revenue: 52532000 Open source
20062006-12-31	Net margin	26.3%	Net Income: 15988000 Open source Revenue: 60689000 Open source
20072007-12-31	Net margin	-54.6%	Net Income: -45376000 Open source Revenue: 83161000 Open source
20082008-12-31	Net margin	19.8%	Net Income: 21412000 Open source Revenue: 108175000 Open source
20052005-12-31	Free cash flow margin	-18.6%	Revenue: 52532000 Open source Operating Cash Flow: 3885000 Open source Capital Expenditure: 13669000 Open source
20062006-12-31	Free cash flow margin	88.6%	Revenue: 60689000 Open source Operating Cash Flow: 60027000 Open source Capital Expenditure: 6261000 Open source
20072007-12-31	Free cash flow margin	62.1%	Revenue: 83161000 Open source Operating Cash Flow: 54369000 Open source Capital Expenditure: 2753000 Open source
20082008-12-31	Free cash flow margin	14.6%	Revenue: 108175000 Open source Operating Cash Flow: 19597000 Open source Capital Expenditure: 3820000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 19.6M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	3885000	Operating Cash Flow: 3885000 Open source
20062006-12-31	Operating cash flow	60027000	Operating Cash Flow: 60027000 Open source
20072007-12-31	Operating cash flow	54369000	Operating Cash Flow: 54369000 Open source
20082008-12-31	Operating cash flow	19597000	Operating Cash Flow: 19597000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 15.8M 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	-9784000	Operating Cash Flow: 3885000 Open source Capital Expenditure: 13669000 Open source
20062006-12-31	Free cash flow	53766000	Operating Cash Flow: 60027000 Open source Capital Expenditure: 6261000 Open source
20072007-12-31	Free cash flow	51616000	Operating Cash Flow: 54369000 Open source Capital Expenditure: 2753000 Open source
20082008-12-31	Free cash flow	15777000	Operating Cash Flow: 19597000 Open source Capital Expenditure: 3820000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

46.8% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Liabilities / assets	Not reported	Total Assets: 185910000 Open source
20062006-12-31	Liabilities / assets	37.2%	Total Liabilities: 104690000 Open source Total Assets: 281365000 Open source
20072007-12-31	Liabilities / assets	53.2%	Total Liabilities: 152404000 Open source Total Assets: 286698000 Open source
20082008-12-31	Liabilities / assets	46.8%	Total Liabilities: 141130000 Open source Total Assets: 301566000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.8× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Current assets / current liabilities	4.2×	Current Assets: 119610000 Open source Current Liabilities: 28488000 Open source
20062006-12-31	Current assets / current liabilities	7.15×	Current Assets: 210207000 Open source Current Liabilities: 29386000 Open source
20072007-12-31	Current assets / current liabilities	1.42×	Current Assets: 81103000 Open source Current Liabilities: 57079000 Open source
20082008-12-31	Current assets / current liabilities	1.8×	Current Assets: 113638000 Open source Current Liabilities: 62994000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	USD 9.97 million Exact value Exact value: 9972000 USD 2005-01-01 – 2005-12-31: 9972000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVEN PHARMACEUTICALS INC · 2005-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Net Income: 9972000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9972000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-08-002536.txt#22299 The citation records this snapshot. The page link may show a newer release later.	USD 3.89 million Exact value Exact value: 3885000 USD 2005-01-01 – 2005-12-31: 3885000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVEN PHARMACEUTICALS INC · 2005-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Operating Cash Flow: 3885000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3885000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-08-002536.txt#22703 The citation records this snapshot. The page link may show a newer release later.	USD 13.67 million Exact value Exact value: 13669000 USD 2005-01-01 – 2005-12-31: 13669000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVEN PHARMACEUTICALS INC · 2005-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Capital Expenditure: 13669000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13669000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-08-002536.txt#22760 The citation records this snapshot. The page link may show a newer release later.	−USD 9.78 million Calculation and evidence 3885000 − 13669000 USD Exact free cash flow: -9784000 USD 2005-01-01 – 2005-12-31: 3885000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 13669000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVEN PHARMACEUTICALS INC · 2005-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Free cash flow: -9784000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3885000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-08-002536.txt#22703 Input fundies:CapitalExpenditure: 13669000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-08-002536.txt#22760 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 15.99 million Exact value Exact value: 15988000 USD 2006-01-01 – 2006-12-31: 15988000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVEN PHARMACEUTICALS INC · 2006-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Net Income: 15988000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 15988000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20442 The citation records this snapshot. The page link may show a newer release later.	USD 60.03 million Exact value Exact value: 60027000 USD 2006-01-01 – 2006-12-31: 60027000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVEN PHARMACEUTICALS INC · 2006-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Operating Cash Flow: 60027000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 60027000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20891 The citation records this snapshot. The page link may show a newer release later.	USD 6.26 million Exact value Exact value: 6261000 USD 2006-01-01 – 2006-12-31: 6261000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVEN PHARMACEUTICALS INC · 2006-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Capital Expenditure: 6261000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6261000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20933 The citation records this snapshot. The page link may show a newer release later.	USD 53.77 million Calculation and evidence 60027000 − 6261000 USD Exact free cash flow: 53766000 USD 2006-01-01 – 2006-12-31: 60027000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 6261000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVEN PHARMACEUTICALS INC · 2006-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Free cash flow: 53766000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 60027000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20891 Input fundies:CapitalExpenditure: 6261000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20933 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 45.38 million Exact value Exact value: -45376000 USD 2007-01-01 – 2007-12-31: -45376000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVEN PHARMACEUTICALS INC · 2007-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Net Income: -45376000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45376000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20442 The citation records this snapshot. The page link may show a newer release later.	USD 54.37 million Exact value Exact value: 54369000 USD 2007-01-01 – 2007-12-31: 54369000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVEN PHARMACEUTICALS INC · 2007-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Operating Cash Flow: 54369000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 54369000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20891 The citation records this snapshot. The page link may show a newer release later.	USD 2.75 million Exact value Exact value: 2753000 USD 2007-01-01 – 2007-12-31: 2753000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVEN PHARMACEUTICALS INC · 2007-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Capital Expenditure: 2753000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2753000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20933 The citation records this snapshot. The page link may show a newer release later.	USD 51.62 million Calculation and evidence 54369000 − 2753000 USD Exact free cash flow: 51616000 USD 2007-01-01 – 2007-12-31: 54369000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 2753000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVEN PHARMACEUTICALS INC · 2007-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Free cash flow: 51616000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 54369000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20891 Input fundies:CapitalExpenditure: 2753000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20933 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	USD 21.41 million Exact value Exact value: 21412000 USD 2008-01-01 – 2008-12-31: 21412000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVEN PHARMACEUTICALS INC · 2008-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Net Income: 21412000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 21412000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20442 The citation records this snapshot. The page link may show a newer release later.	USD 19.6 million Exact value Exact value: 19597000 USD 2008-01-01 – 2008-12-31: 19597000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVEN PHARMACEUTICALS INC · 2008-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Operating Cash Flow: 19597000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 19597000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20891 The citation records this snapshot. The page link may show a newer release later.	USD 3.82 million Exact value Exact value: 3820000 USD 2008-01-01 – 2008-12-31: 3820000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NOVEN PHARMACEUTICALS INC · 2008-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Capital Expenditure: 3820000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3820000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20933 The citation records this snapshot. The page link may show a newer release later.	USD 15.78 million Calculation and evidence 19597000 − 3820000 USD Exact free cash flow: 15777000 USD 2008-01-01 – 2008-12-31: 19597000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 3820000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NOVEN PHARMACEUTICALS INC · 2008-12-31 NOVEN PHARMACEUTICALS INC (edgar:815838) Free cash flow: 15777000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:04:58Z Snapshot: 524a43b8cd3a42a5337510c26696723106ea7e5286d1db569848254e6ccd410d Dimensions: Consolidated View: https://fundies.io/companies/edgar/815838?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 19597000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20891 Input fundies:CapitalExpenditure: 3820000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/815838/0000950144-09-002145.txt#20933 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

64 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000815838, 815838, edgar:815838

NOVEN PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation